{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:08:36Z","timestamp":1790644116167,"version":"4.1.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cognitive impairment is a significant complication in Parkinson\u2019s disease (PD), impacting quality of life and increasing caregiver burden. This study investigates the association between the blood urea nitrogen to albumin ratio (BAR) and cognitive impairment in PD patients, aiming to identify BAR as a potential biomarker for early detection and monitoring of cognitive decline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from 1,312 PD patients were extracted from the PPMI database. The cognitive assessment tool was the Montreal Cognitive Assessment (MoCA) score and other cognitive metrics. The association between BAR and cognitive impairment was assessed using multivariate linear regression models to evaluate the continuous relationship, and logistic regression models to examine the binary outcomes. Furthermore, subgroup and sensitivity analyses were carried out to ensure the reliability of the results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Higher BAR levels were significantly associated with lower MoCA scores in PD patients, independent of other confounding variables (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.21, 95% CI\u202f=\u202f-0.35\u202f~\u202f\u22120.07,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.003). The odds ratio for cognitive impairment, defined by a MoCA score cutoff of 26, was 1.15 (95% CI: 1.02\u20131.30,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.027). Further analysis revealed that BAR was negatively correlated with the Benton Judgment of Line Orientation MOANS Scale Score and the Symbol-Digit Modalities Test\n                      <jats:italic>T<\/jats:italic>\n                      -score, and positively correlated with the Trail Making Test Part A Reverse\n                      <jats:italic>Z<\/jats:italic>\n                      -score. These findings suggest that higher BAR levels are associated with poorer performance in visuospatial abilities, processing speed, and motor function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study underscores the potential utility of BAR as a biomarker for cognitive impairment in PD. Future prospective cohort studies are warranted to validate these findings and explore the potential of BAR in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1614862","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:14:25Z","timestamp":1767935665000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The association between blood urea nitrogen to albumin ratio and cognitive function in Parkinson\u2019s disease patients"],"prefix":"10.3389","volume":"16","author":[{"given":"Wen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-fang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-juan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/mds.21813","article-title":"Nonmotor symptoms as presenting complaints in Parkinson\u2019s disease: a clinicopathological study","volume":"23","author":"O\u2019Sullivan","year":"2008","journal-title":"Mov Disord"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1080\/13803395.2015.1073227","article-title":"Parkinson\u2019s disease dementia: diagnostic criteria and risk factor review","volume":"37","author":"Vasconcellos","year":"2015","journal-title":"J Clin Exp Neuropsychol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s13311-020-00963-x","article-title":"Approach to cognitive impairment in Parkinson\u2019s disease","volume":"17","author":"Zhang","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/0891988716654985","article-title":"Parkinson disease and dementia","volume":"29","author":"Garcia-Ptacek","year":"2016","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"e2045","DOI":"10.1212\/WNL.0000000000006576","article-title":"Early predictors of mortality in parkinsonism and parkinson disease: a population-based study","volume":"91","author":"B\u00e4ckstr\u00f6m","year":"2018","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson\u2019s disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"743754","DOI":"10.3389\/fnagi.2021.743754","article-title":"Parkinson\u2019s disease dementia: synergistic effects of alpha-synuclein, tau, beta-amyloid, and iron","volume":"13","author":"Han","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.parkreldis.2013.09.025","article-title":"The influence of age and gender on motor and non-motor features of early parkinson\u2019s disease: initial findings from the oxford parkinson disease center (OPDC) discovery cohort","volume":"20","author":"Szewczyk-Krolikowski","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"967332","DOI":"10.3389\/fnut.2022.967332","article-title":"Association between blood urea nitrogen to serum albumin ratio and in-hospital mortality of patients with sepsis in intensive care: a retrospective analysis of the fourth-generation medical information mart for intensive care database","volume":"9","author":"Cai","year":"2022","journal-title":"Front Nutr"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3390\/tropicalmed7080150","article-title":"Fibrinogen-to-albumin ratio and blood urea nitrogen-to-albumin ratio in COVID-19 patients: a systematic review and meta-analysis","volume":"7","author":"Ulloque-Badaracco","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"801708","DOI":"10.3389\/fsurg.2022.801708","article-title":"Blood urea nitrogen-to-albumin ratio in predicting long-term mortality in patients following coronary artery bypass grafting: an analysis of the MIMIC-III database","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Surg"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ajem.2020.12.022","article-title":"Predictive performance of blood urea nitrogen to serum albumin ratio in elderly patients with gastrointestinal bleeding","volume":"41","author":"Bae","year":"2021","journal-title":"Am J Emerg Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.5535\/arm.2016.40.6.1082","article-title":"Risk factors for delirium during acute and subacute stages of various disorders in patients admitted to rehabilitation units","volume":"40","author":"Jang","year":"2016","journal-title":"Ann Rehabil Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1038\/s41598-025-86715-3","article-title":"A machine learning-based model for predicting the risk of cognitive frailty in elderly patients on maintenance hemodialysis","volume":"15","author":"Cao","year":"2025","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1038\/s41598-024-54919-8","article-title":"Blood urea nitrogen to albumin ratio is associated with cerebral small vessel diseases","volume":"14","author":"Nam","year":"2024","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/JSS.V045.I03","article-title":"Mice: multivariate imputation by chained equations in R","volume":"45","author":"Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3988\/jcn.2019.15.4.517","article-title":"The influence of body mass index at diagnosis on cognitive decline in parkinson\u2019s disease","volume":"15","author":"Yoo","year":"2019","journal-title":"J Clin Neurol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e2268","DOI":"10.1212\/WNL.0000000000200268","article-title":"Repeatedly measured serum creatinine and cognitive performance in midlife: the cardiovascular risk in young finns study","volume":"98","author":"Hakala","year":"2022","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3233\/JAD-220343","article-title":"Implications of liver enzymes in the pathogenesis of Alzheimer\u2019s disease","volume":"88","author":"Han","year":"2022","journal-title":"J Alzheimer's Dis"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/jcm13020465","article-title":"Glucose metabolism and cognitive decline in progressive supranuclear palsy and corticobasal syndrome: a preliminary study","volume":"13","author":"Madetko-Alster","year":"2024","journal-title":"J Clin Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.31083\/j.jin2309168","article-title":"Relationships between serum lipid, uric acid levels and mild cognitive impairment in parkinson\u2019s disease and multiple system atrophy","volume":"23","author":"Ren","year":"2024","journal-title":"J Integr Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/jnci\/80.15.1198","article-title":"Regression models in clinical studies: determining relationships between predictors and response","volume":"80","author":"Harrell","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1080\/15376516.2020.1760984","article-title":"Predictable hematological markers associated with cognitive decline in valid rodent models of cognitive impairment","volume":"30","author":"Pondugula","year":"2020","journal-title":"Toxicol Mech Methods"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"5583707","DOI":"10.1155\/2024\/5583707","article-title":"Establishment, prediction, and validation of a nomogram for cognitive impairment in elderly patients with diabetes","volume":"2024","author":"Wu","year":"2024","journal-title":"J Diabetes Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e14502","DOI":"10.1111\/cns.14502","article-title":"Association between nutritional status and gait performance in Alzheimer\u2019s disease","volume":"30","author":"He","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2217276","DOI":"10.1080\/0886022X.2023.2217276","article-title":"Altered spontaneous brain activities in maintenance hemodialysis patients with cognitive impairment and the construction of cognitive function prediction models","volume":"45","author":"Sun","year":"2023","journal-title":"Ren Fail"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1376693","DOI":"10.3389\/fnagi.2024.1376693","article-title":"A glimpse into the future: revealing the key factors for survival in cognitively impaired patients","volume":"16","author":"Wei","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e30324","DOI":"10.1097\/MD.0000000000030324","article-title":"Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease","volume":"101","author":"Sun","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/156720510790274392","article-title":"Serum albumin concentration and cognitive impairment","volume":"7","author":"Llewellyn","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13195-024-01407-w","article-title":"The relationship between amyloid pathology, cerebral small vessel disease, glymphatic dysfunction, and cognition: a study based on Alzheimer\u2019s disease continuum participants","volume":"16","author":"Hong","year":"2024","journal-title":"Alzheimer's Res Ther"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1172\/JCI37672","article-title":"Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure","volume":"120","author":"D\u2019Apolito","year":"2010","journal-title":"J Clin Invest"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/toxins10100410","article-title":"Urea memory: transient cell exposure to urea causes persistent mitochondrial ROS production and endothelial dysfunction","volume":"10","author":"d\u2019Apolito","year":"2018","journal-title":"Toxins (Basel)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"13248","DOI":"10.1038\/s41598-024-64073-w","article-title":"A cross-sectional national health and nutrition examination survey-based study of the association between systemic immune-inflammation index and blood urea nitrogen levels in United States adolescents","volume":"14","author":"Guo","year":"2024","journal-title":"Sci Rep"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.atherosclerosis.2015.01.034","article-title":"Urea-induced ROS cause endothelial dysfunction in chronic renal failure","volume":"239","author":"D\u2019Apolito","year":"2015","journal-title":"Atherosclerosis"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2017.06.028","article-title":"Urea-induced ROS accelerate senescence in endothelial progenitor cells","volume":"263","author":"D\u2019Apolito","year":"2017","journal-title":"Atherosclerosis"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association\/american stroke association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1212\/WNL.0000000000003837","article-title":"Intracranial atherosclerosis and dementia","volume":"88","author":"Dearborn","year":"2017","journal-title":"Neurology"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ejim.2013.05.015","article-title":"Clinical indications for the albumin use: still a controversial issue","volume":"24","author":"Caraceni","year":"2013","journal-title":"Eur J Intern Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1515\/RNS.2011.028","article-title":"Current perspectives on potential role of albumin in neuroprotection","volume":"22","author":"Prajapati","year":"2011","journal-title":"Rev Neurosci"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1212\/WNL.0000000000010005","article-title":"Serum albumin and beta-amyloid deposition in the human brain","volume":"95","author":"Kim","year":"2020","journal-title":"Neurology"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol Dis"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.bbamem.2018.01.015","article-title":"Serum albumin impedes the amyloid aggregation and hemolysis of human islet amyloid polypeptide and alpha synuclein","volume":"1860","author":"Kakinen","year":"2018","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40035-020-00226-x","article-title":"Cross-talks among GBA mutations, glucocerebrosidase, and \u03b1-synuclein in GBA-associated parkinson\u2019s disease and their targeted therapeutic approaches: a comprehensive review","volume":"10","author":"Behl","year":"2021","journal-title":"Transl Neurodegener"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13195-023-01244-3","article-title":"Shared genetic risk loci between Alzheimer\u2019s disease and related dementias, parkinson\u2019s disease, and amyotrophic lateral sclerosis","volume":"15","author":"Wainberg","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1007\/s00415-024-12374-5","article-title":"GBA moderates cognitive reserve\u2019s effect on cognitive function in patients with parkinson\u2019s disease","volume":"271","author":"Chang","year":"2024","journal-title":"J Neurol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"106887","DOI":"10.1016\/j.nbd.2025.106887","article-title":"Influence of WWOX\/MAF genes on cognitive performance in patients with Parkinson\u2019s disease","volume":"208","author":"Yuan","year":"2025","journal-title":"Neurobiol Dis"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1614862\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T05:14:26Z","timestamp":1767935666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1614862\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":50,"alternative-id":["10.3389\/fneur.2025.1614862"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1614862","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1614862"}}